Virtus Lifesci Biotech Clinical Trials ETF
(BBC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBC | VHT | IBB | ||
| Company | Virtus Lifesci Biotech Clinical Trials ETF | Healthcare ETF Vanguard | Nasdaq Biotechnology Ishares ETF | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NASDAQ | ||
| Open | 40.81 | 290.98 | 175.02 | ||
| High | 41.24 | 291.89 | 175.02 | ||
| Low | 40.04 | 288.31 | 173.11 | ||
| Latest | 40.95 | 288.95 | 174.37 | ||
| Change | +0.08 | -2.25 | -0.61 | ||
| % Change | +0.20% | -0.77% | -0.35% | ||
| Volume | 30,500 | 224,400 | 1,569,900 | ||
| 20-Day Average Volume | 21,090 | 232,268 | 1,921,095 | ||
| Previous Close | 40.87 | 291.20 | 174.98 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 41.34 | 290.22 | 173.49 | ||
| 20-Day Raw Stochastic | 44.73% | 35.36% | 66.20% | ||
| 20-Day Relative Strength | 53.43 | 50.37 | 54.07 | ||
| Weighted Alpha | +106.49 | +12.05 | +34.21 | ||
| Today's Opinion | 80% Buy | 64% Buy | 96% Buy | ||
| Previous Opinion | 80% Buy | 96% Buy | 96% Buy | ||
| Last Month's Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.31% since 02/02/26 | -0.02% since 02/02/26 | +0.13% since 02/02/26 | ||
| Low | 38.83 on 02/05/26 | 285.66 on 02/03/26 | 169.67 on 02/05/26 | ||
| High | 42.90 on 02/03/26 | 291.89 on 02/09/26 | 176.86 on 02/03/26 | ||
| 1-Month | |||||
| %Chg | +3.53% since 01/09/26 | -1.37% since 01/09/26 | +1.15% since 01/09/26 | ||
| Low | 38.40 on 01/12/26 | 284.77 on 01/30/26 | 165.81 on 01/20/26 | ||
| High | 44.10 on 01/22/26 | 296.59 on 01/22/26 | 178.74 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +37.93% since 11/07/25 | +5.97% since 11/07/25 | +10.56% since 11/07/25 | ||
| Low | 30.47 on 11/11/25 | 272.05 on 11/10/25 | 158.37 on 11/10/25 | ||
| High | 44.10 on 01/22/26 | 298.61 on 01/07/26 | 179.64 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +94.68% since 08/08/25 | +19.82% since 08/08/25 | +32.06% since 08/08/25 | ||
| Low | 20.87 on 08/11/25 | 241.12 on 08/11/25 | 131.36 on 08/11/25 | ||
| High | 44.10 on 01/22/26 | 298.61 on 01/07/26 | 179.64 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 36,855 | 17,386,122 | 8,631,314 | ||
| Shares Outstanding, K | 900 | 60,170 | 49,500 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 1.01 | 0.67 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.655 on 12/22/25 | 1.665 on 12/17/25 | 0.183 on 12/16/25 | ||
| Next Ex-Dividends Date | 12/22/25 | 12/17/25 | 12/16/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.40 | 26.01 | ||